Inventor
Drew Dudgeon
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
A61NElectrotherapy14%
PatentTitleYear
12,344,677Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof202512,331,127Therapeutic uses of anti-GITR antibodies202511,787,867Anti-GITR antibodies and uses thereof202311,155,633Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to REGENERON PHARMA (4)· patent assignee history
2021Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 4 | 2021–2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2021–2025 |